Viewing Study NCT02293356


Ignite Creation Date: 2025-12-24 @ 11:31 PM
Ignite Modification Date: 2025-12-25 @ 9:19 PM
Study NCT ID: NCT02293356
Status: UNKNOWN
Last Update Posted: 2015-08-19
First Post: 2014-10-31
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Phase IV Clinical Trial of Nimotuzumab in the Treatment of Nasopharyngeal Carcinoma
Sponsor: Biotech Pharmaceutical Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module